Alchemi Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Alchemi Wealth's BMY Position: Q2 2026 in Review
Alchemi Wealth increased its Bristol-Myers Squibb (BMY) stake by 0.11% in Q2 2026, buying an estimated $230 and bringing the position to 3,579 shares worth $206K. The position accounts for 0.1% of the portfolio, ranked #166.
Alchemi Wealth first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $247K in Q4 2025. 2,513 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Alchemi Wealth held 3,579 shares of Bristol-Myers Squibb worth $206K as of Q2 2026.
- Alchemi Wealth bought 4 Bristol-Myers Squibb shares in Q2 2026, an estimated $230.
- Bristol-Myers Squibb made up 0.1% of Alchemi Wealth's portfolio in Q2 2026, its #166 holding.
- Alchemi Wealth first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- Alchemi Wealth's Bristol-Myers Squibb position peaked at $247K in Q4 2025.
- 2,513 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Alchemi Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.